STOK Earnings

Quarterly EPS
$-0.47
Q3 2024
$-0.18
Q4 2024
$1.95
Q1 2025
$-0.40
Q2 2025
$-0.65
Q3 2025
$-0.93
Q4 2025
$-0.79
Q1 2026
$-0.93
Q2 2026
Latest Revenue9.3M
Latest Net Income-61618000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.939.3M-61618000-32.5%-132.5%
Q1 2026-$0.796.2M-50003000-96.1%-140.5%
Q4 2025-$0.931.4M-57934000-93.8%-416.7%
Q3 2025-$0.6510.6M-38347000+117.2%-38.3%
Q2 2025-$0.4013.8M-23483000+186.0%+13.0%
Q1 2025$1.95158.6M112.9M+3,661.1%+442.1%
Q4 2024-$0.1822.6M-10482000+707.1%+70.0%
Q3 2024-$0.474.9M-26430000+47.9%+14.5%
Q2 2024-$0.464.8M-25695000
Q1 2024-$0.574.2M-26374000
Q4 2023-$0.602.8M-26958000
Q3 2023-$0.553.3M-24542000
Stoke Therapeutics (STOK) — Earnings